1. Home
  2. VRDN vs KDK Comparison

VRDN vs KDK Comparison

Compare VRDN & KDK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • KDK
  • Stock Information
  • Founded
  • VRDN 2006
  • KDK 2018
  • Country
  • VRDN United States
  • KDK United States
  • Employees
  • VRDN N/A
  • KDK N/A
  • Industry
  • VRDN Medical Specialities
  • KDK EDP Services
  • Sector
  • VRDN Health Care
  • KDK Technology
  • Exchange
  • VRDN Nasdaq
  • KDK Nasdaq
  • Market Cap
  • VRDN 1.6B
  • KDK 1.3B
  • IPO Year
  • VRDN N/A
  • KDK N/A
  • Fundamental
  • Price
  • VRDN $20.78
  • KDK $9.00
  • Analyst Decision
  • VRDN Strong Buy
  • KDK
  • Analyst Count
  • VRDN 10
  • KDK 0
  • Target Price
  • VRDN $36.33
  • KDK N/A
  • AVG Volume (30 Days)
  • VRDN 718.1K
  • KDK 2.0M
  • Earning Date
  • VRDN 11-11-2025
  • KDK 11-15-2025
  • Dividend Yield
  • VRDN N/A
  • KDK N/A
  • EPS Growth
  • VRDN N/A
  • KDK N/A
  • EPS
  • VRDN N/A
  • KDK N/A
  • Revenue
  • VRDN $305,000.00
  • KDK $16,079,999.00
  • Revenue This Year
  • VRDN N/A
  • KDK N/A
  • Revenue Next Year
  • VRDN $34,044.63
  • KDK N/A
  • P/E Ratio
  • VRDN N/A
  • KDK N/A
  • Revenue Growth
  • VRDN 5.90
  • KDK N/A
  • 52 Week Low
  • VRDN $9.90
  • KDK $5.77
  • 52 Week High
  • VRDN $27.20
  • KDK $10.48
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 54.30
  • KDK N/A
  • Support Level
  • VRDN $20.69
  • KDK N/A
  • Resistance Level
  • VRDN $22.37
  • KDK N/A
  • Average True Range (ATR)
  • VRDN 0.97
  • KDK 0.00
  • MACD
  • VRDN -0.06
  • KDK 0.00
  • Stochastic Oscillator
  • VRDN 54.71
  • KDK 0.00

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About KDK Kodiak AI Inc. Common Stock

Kodiak AI Inc is engaged in the commercial trucking industry and the public sector, based on AI-powered autonomous vehicle technology.

Share on Social Networks: